Back

High dosages of betablockers are related to left ventricular reverse remodelling in patients with recent-onset non-ischaemic dilated cardiomyopathy

29 June 2021 (08:00 - 23:59)
Organised by:
Congress Presentation Part of: ePoster session Ventricular Remodelling HFA Premium Access Heart Failure 2021

About the speaker

Photo
Doctor Barbara M Serrano Munoz

University Hospital Of Jerez of the Frontera, Jerez de la Frontera (Spain)

738 More presentations in this session

Presentation thumbnail
Atrial lead insertion during cardiac implantable electronic devices implantation in patients with atrial arrhythmia on hospital admission, when does the struggle for sinus rhythm make sense?
Assistant Professor N. Radovanovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Features of the remodeling of atria and pulmonary veins in CHF patients with paroxysmal AF and permanent AF
Assistant Professor V. Kirillova (Ekaterinburg, RU)
Abstract Slides
Presentation thumbnail
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum
Doctor D. Moysidis (Zurich, CH)
Abstract Slides
Presentation thumbnail
Impact of cardiac contractility modulation on ventricular rhythm and conduction disorders in patients with heart failure with reduced ejection fraction and various forms of atrial fibrillation
Doctor A. Safiullina (Moscow, RU)
Abstract Slides
Presentation thumbnail
Was a difference between late and early new-onset of atrial fibrillation in non st-elevation myocardial infarction?
Doctor H. Santos (Lisboa, PT)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

Heart Failure 2021

29 June 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Prevalence of early and late left ventricular reverse remodelling in dilated cardiomyopathy under optimal medical therapy
22 May 2023
thumbnail
Congress Presentation
Atrioventricular conduction disorders associated to betablocker treatment in patients with heart failure
20 May 2023
thumbnail
Congress Presentation
Long-term benefit of vasodilating beta-blocker in patients with mildly reduced left ventricular systolic function after acute myocardial infarction
20 May 2023
thumbnail
Congress Presentation
Association between dose of medications and mortality in heart failure with reduced ejection fraction: a systematic review and dose-response meta-analysis
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources